SPOP and breast cancer: Importantly, circLRBA could competitively combine with E3 ubiquitin ligase SPOP to suppress the Twist1 ubiquitination degradation and enhances PD‐L1 transcriptional activity, thus promoting EMT, immune evasion, chemoresistance and BC progression.